Development of an Integrated Performance Measurement (PM) Model for Pharmaceutical Industry

被引:0
作者
Shabaninejad, Hosein [1 ]
Mirsalehian, Mohammad Hossein [2 ]
Mehralian, Gholamhossein [3 ]
机构
[1] Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, Iran
[2] Univ Tehran, Fac Entreprenurship, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharma Management & Pharmacoecon, Tehran, Iran
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2014年 / 13卷
关键词
Performance; Measurement; Key indicators; Pharmaceutical company; Expert opinion; BALANCED SCORECARD; MANAGEMENT; SYSTEM; MARKET;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
With respect to special characteristics of pharmaceutical industry and lack of reported performance measure, this study tries to design an integrated PM model for pharmaceutical companies. For generating this model; we first identified the key performance indicators (KPIs) and the key result indicators (KRIs) of a typical pharmaceutical company. Then, based on experts. opinions, the identified indicators were ranked with respect to their importance, and the most important of them were selected to be used in the proposed model; In this model, we identified 25 KPIs and 12 KRIs. Although, this model is mostly appropriate to measure the performances of pharmaceutical companies, it can be also used to measure the performances of other industries with some modifications. We strongly recommend pharmaceutical managers to link these indicators with their payment and reward system, which can dramatically affect the performance of employees, and consequently their organization's success.
引用
收藏
页码:207 / 215
页数:9
相关论文
共 45 条
[31]   The balanced scorecard: a foundation for the strategic management of information systems [J].
Martinsons, M ;
Davison, R ;
Tse, D .
DECISION SUPPORT SYSTEMS, 1999, 25 (01) :71-88
[32]   Prioritization of intellectual capital indicators in knowledge-based industries: Evidence from pharmaceutical industry [J].
Mehralian, Gholamhossein ;
Rasekh, Hamid Reza ;
Akhavan, Peyman ;
Ghatari, Ali Rajabzadeh .
INTERNATIONAL JOURNAL OF INFORMATION MANAGEMENT, 2013, 33 (01) :209-216
[33]   Intellectual capital and corporate performance in Iranian pharmaceutical industry [J].
Mehralian, Gholamhossein ;
Rajabzadeh, Ali ;
Sadeh, Mohammad Reza ;
Rasekh, Hamid Reza .
JOURNAL OF INTELLECTUAL CAPITAL, 2012, 13 (01) :138-+
[34]  
Moses Anna, 2008, Journal of Purchasing and Supply Management, V14, P87, DOI 10.1016/j.pursup.2007.11.003
[35]   Development of maintenance function performance measurement framework and indicators [J].
Muchiri, Peter ;
Pintelon, Liliane ;
Gelders, Ludo ;
Martin, Harry .
INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS, 2011, 131 (01) :295-302
[36]   Performance measurement system design - A literature review and research agenda [J].
Neely, A ;
Gregory, M ;
Platts, K .
INTERNATIONAL JOURNAL OF OPERATIONS & PRODUCTION MANAGEMENT, 2005, 25 (12) :1228-1263
[37]  
Neely A., 2002, BUSINESS PERFORMANCE
[38]  
Neely A.D., 2002, Prentice Hall Financial Times
[39]  
Parmenter D, 2010, KEY PERFORMANCE IND
[40]   New product development process and time-to-market in the generic pharmaceutical industry [J].
Prasnikar, Janez ;
Skerlj, Tina .
INDUSTRIAL MARKETING MANAGEMENT, 2006, 35 (06) :690-702